NSCLC comprises heterogeneous molecular subtypes harboring mutations in various oncogenes, including EGFR, ALK receptor tyrosine kinase (ALK), ROS proto-oncogene 1 (ROS1), RET, B-Raf proto-oncogene, and human epidermal growth factor receptor 2. Here, ALK is linked to non-small cell lung carcinoma.